Ground Swell Capital’s IN8bio INAB Stock Holding History

Ground Swell Capital’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-545	Closed	-$19.3K	–	197
2024 Q1	$19.3K	Buy	+545	New	+$20.6K	0.02%	59

Other funds holding INAB

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Ground Swell Capital's INAB Position: Q2 2024 in Review

Ground Swell Capital sold out of IN8bio (INAB) in Q2 2024, closing a stake of 545 shares — an estimated $19.3K sold.

Ground Swell Capital first reported a position in INAB in Q1 2024 and held it in 1 quarter. The position peaked at $19.3K in Q1 2024. 26 funds tracked by Wall St. Rank hold INAB as of Q2 2024.

Ground Swell Capital reported no remaining IN8bio position as of Q2 2024 after selling out during the quarter.
Ground Swell Capital sold 545 IN8bio shares in Q2 2024, an estimated $19.3K.
Ground Swell Capital first reported a position in IN8bio in Q1 2024 and held it in 1 quarter.
Ground Swell Capital's IN8bio position peaked at $19.3K in Q1 2024.
26 funds tracked by Wall St. Rank held IN8bio as of Q2 2024.

Based on Ground Swell Capital's 13F filing for Q2 2024, filed 7 Aug 2024.